Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 743-759 |
| Number of pages | 17 |
| Journal | Drug Safety |
| Volume | 37 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
Cite this
}
Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. / Beckmann, Jürgen; Hagemann, Ulrich; Bahri, Priya; Bate, Andrew; Boyd, Ian; Pan, Gerald; Edwards, Brian; Edwards, I.; Hartigan-Go, Kenneth; Lindquist, Marie; MCEWEN, John; Moride, Yola; Olsson, Sten; Pal, Shanthi; Soulaymani-Bencheikh, Rachida; Tuccori, Marco; Vaca, Claudia; Wong, Ian.
In: Drug Safety, Vol. 37, No. 10, 2014, p. 743-759.Research output: Contribution to journal › Article
TY - JOUR
T1 - Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
AU - Beckmann, Jürgen
AU - Hagemann, Ulrich
AU - Bahri, Priya
AU - Bate, Andrew
AU - Boyd, Ian
AU - Pan, Gerald
AU - Edwards, Brian
AU - Edwards, I.
AU - Hartigan-Go, Kenneth
AU - Lindquist, Marie
AU - MCEWEN, John
AU - Moride, Yola
AU - Olsson, Sten
AU - Pal, Shanthi
AU - Soulaymani-Bencheikh, Rachida
AU - Tuccori, Marco
AU - Vaca, Claudia
AU - Wong, Ian
PY - 2014
Y1 - 2014
N2 - The importance of pharmacovigilance (PV) for safe medicines and their safe use has increasingly been recognized during the last few years [1]. PV has been subject of intense research and regulation. In particular, it has earned more and more importance and attention in low-resource countries. This is largely due to the globalisation of trade and the availability of new, highly effective but potentially harmful chemical medicinal products in those parts of the world where traditional treatments, in particular herbal or other complementary remedies, used to prevail. A plethora of publications, guidelines and information about newly observed or further investigated adverse drug reactions (ADRs) from all over the world creates a growing burden for people working with medicines or patients to keep abreast of this development. Largely due to the global availability of information through the Internet, patients are nowadays more and more critical and often concerned about, or even frightened of, potential ADRs of their medicines. This poses an additional demand on the up-todate capacities of their doctors and other healthcare professionals (HCPs). A particular challenge is the multidisciplinary character of PV which requires know-how in topics as different as molecular mechanisms of ADRs, clinical medicine, pharmacoepidemiology, information technology, pharmaceutical manufacturing, legal aspects, public health situations on various levels, and traditions in different regions of the world. Also, theoretical knowledge needs supplementing with experience and practical skills
AB - The importance of pharmacovigilance (PV) for safe medicines and their safe use has increasingly been recognized during the last few years [1]. PV has been subject of intense research and regulation. In particular, it has earned more and more importance and attention in low-resource countries. This is largely due to the globalisation of trade and the availability of new, highly effective but potentially harmful chemical medicinal products in those parts of the world where traditional treatments, in particular herbal or other complementary remedies, used to prevail. A plethora of publications, guidelines and information about newly observed or further investigated adverse drug reactions (ADRs) from all over the world creates a growing burden for people working with medicines or patients to keep abreast of this development. Largely due to the global availability of information through the Internet, patients are nowadays more and more critical and often concerned about, or even frightened of, potential ADRs of their medicines. This poses an additional demand on the up-todate capacities of their doctors and other healthcare professionals (HCPs). A particular challenge is the multidisciplinary character of PV which requires know-how in topics as different as molecular mechanisms of ADRs, clinical medicine, pharmacoepidemiology, information technology, pharmaceutical manufacturing, legal aspects, public health situations on various levels, and traditions in different regions of the world. Also, theoretical knowledge needs supplementing with experience and practical skills
KW - pharmacovigilance
KW - safe medicines and their safe use
KW - research
KW - regulation
U2 - 10.1007/s40264-014-0216-1
DO - 10.1007/s40264-014-0216-1
M3 - Article
VL - 37
SP - 743
EP - 759
JO - Medical Toxicology and Adverse Drug Experience
JF - Medical Toxicology and Adverse Drug Experience
SN - 0114-5916
IS - 10
ER -